Gara Jalqabaatti › Glioblastoma › Minnesota
Qorannoo klinikaalii Glioblastoma Minnesota keessatti
Qorannoo 19 Glioblastoma f Minnesota keessatti hirmaatuu jiru.
Magaalota Minnesota keessatti
Takkalaa qorannoo (Ingiliffa)
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
- Mayo Clinic in Rochester, Rochester
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT05432804A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- Allina Health Systems/Abbott Northwestern Hospital, Minneapolis
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT03970447GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
- Mayo Clinic in Rochester, Rochester
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07301268REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma
- University of Minnesota Radiation Oncology, Minneapolis
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07831772SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Mayo Clinic - Rochester, Rochester
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT05303519Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma
- Mayo Clinic in Rochester, Rochester
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT07076472Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions
- Mayo Clinic in Rochester, Rochester
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT04047264Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
- Mayo Clinic in Rochester, Rochester
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT07091864A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial
- Mayo Clinic in Rochester, Rochester
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT07074756Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
- Mayo Clinic, Rochester
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 17-Ado-2026 · NCT07225621Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
- Mayo Clinic in Rochester, Rochester
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Wax-2026 · NCT07468136Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
- Mayo Clinic, Rochester
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 19 fi ol · Saalaa hunda · Haaromfame 08-Wax-2026 · NCT06011109First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma
- Elizabeth C. Neil, MD, Minneapolis
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 01-Cam-2026 · NCT07560865ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma
- Mayo Clinic in Rochester, Rochester
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Elb-2026 · NCT05917145A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
- Mayo Clinic Hospital, Rochester
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Elb-2026 · NCT07185880Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Mayo Clinic Cancer Center, Rochester
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Elb-2026 · NCT06810544Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma
- Mayo Clinic, Rochester
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Ama-2026 · NCT05465954SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Duluth
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
- Mayo Clinic, Rochester
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Sad-2024 · NCT06160206Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.